“Association of Ruxolitinib Cream Initiation With Continued Reduction in Use of Other Topical Treatments, Oral Corticosteroids, and Biologics for Atopic Dermatitis”, J of Skin, vol. 8, no. 6, p. s455, Nov. 2024, doi: 10.25251/skin.8.supp.455.